These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29911114)

  • 1. Financial toxicity and implications for cancer care in the era of molecular and immune therapies.
    Tran G; Zafar SY
    Ann Transl Med; 2018 May; 6(9):166. PubMed ID: 29911114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States.
    Khera R; Valero-Elizondo J; Okunrintemi V; Saxena A; Das SR; de Lemos JA; Krumholz HM; Nasir K
    JAMA Cardiol; 2018 Aug; 3(8):729-738. PubMed ID: 29971325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies.
    Sensharma A; Yabroff KR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):263-277. PubMed ID: 30628493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States.
    Chen Q; Jain N; Ayer T; Wierda WG; Flowers CR; O'Brien SM; Keating MJ; Kantarjian HM; Chhatwal J
    J Clin Oncol; 2017 Jan; 35(2):166-174. PubMed ID: 27870563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial toxicity in lung cancer.
    Boulanger M; Mitchell C; Zhong J; Hsu M
    Front Oncol; 2022; 12():1004102. PubMed ID: 36338686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial Burden Faced by Families due to Out-of-pocket Expenses during the Treatment of their Cancer Children: An Indian Perspective.
    Sneha LM; Sai J; Ashwini S; Ramaswamy S; Rajan M; Scott JX
    Indian J Med Paediatr Oncol; 2017; 38(1):4-9. PubMed ID: 28469329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
    Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
    Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial Burden in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
    Nipp RD; Kirchhoff AC; Fair D; Rabin J; Hyland KA; Kuhlthau K; Perez GK; Robison LL; Armstrong GT; Nathan PC; Oeffinger KC; Leisenring WM; Park ER
    J Clin Oncol; 2017 Oct; 35(30):3474-3481. PubMed ID: 28817372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumers.
    Whitty JA; Sav A; Kelly F; King MA; McMillan SS; Kendall E; Wheeler AJ
    Aust Health Rev; 2014 Nov; 38(5):589-95. PubMed ID: 25099307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Feasibility Study of an Oncology Financial Navigation Program.
    Shankaran V; Leahy T; Steelquist J; Watabayashi K; Linden H; Ramsey S; Schwartz N; Kreizenbeck K; Nelson J; Balch A; Singleton E; Gallagher K; Overstreet K
    J Oncol Pract; 2018 Feb; 14(2):e122-e129. PubMed ID: 29272200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs.
    Glode AE; May MB
    Pharmacotherapy; 2017 Jan; 37(1):85-93. PubMed ID: 27862122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial toxicity in cancer care.
    O'Connor JM; Kircher SM; de Souza JA
    J Community Support Oncol; 2016 Mar; 14(3):101-6. PubMed ID: 27058866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician and Patient Adjustment to Reference Pricing for Drugs.
    Robinson JC; Whaley C; Brown TT; Dhruva SS
    JAMA Netw Open; 2020 Feb; 3(2):e1920544. PubMed ID: 32022881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses.
    Wagner L; Lacey MD
    Clin J Oncol Nurs; 2004 Jun; 8(3):279-87. PubMed ID: 15208822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial Toxicity of Cancer Care: It's Time to Intervene.
    Zafar SY
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26657334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference Pricing, Consumer Cost-Sharing, and Insurer Spending for Advanced Imaging Tests.
    Robinson JC; Whaley C; Brown TT
    Med Care; 2016 Dec; 54(12):1050-1055. PubMed ID: 27479594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.
    Carrera PM; Kantarjian HM; Blinder VS
    CA Cancer J Clin; 2018 Mar; 68(2):153-165. PubMed ID: 29338071
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.